Latka logo

Valuation · 2022

$6.4B

2024 Revenue

$402.6M

Funding

$829.8M

Team · 2025

2.8K

Founded

2013

Doctolib Revenue, Valuation & Funding (2024)

Doctolib generated $402.6M in revenue in 2024. Source: frontiers.health

Doctolib is a French healthcare technology company that operates the website doctolib.com. The company was founded in 2013 and is headquartered in Paris, France, with additional offices in other parts of Europe. Doctolib's platform provides users with a comprehensive and user-friendly way to book and manage medical appointments online. The platform enables users to search for and book appointments with healthcare professionals, such as doctors, dentists, and therapists, across various specialties and locations. The platform also offers features such as online video consultations, prescription renewals, and medical record access, providing a seamless and integrated healthcare experience for patients. Doctolib serves millions of users across Europe, and partners with over 135,000 healthcare professionals to offer a wide range of medical services. The company is committed to improving access to healthcare and promoting digital transformation in the healthcare industry.

Last updated

Doctolib Revenue

In 2024, Doctolib's revenue reached $402.6M. The company previously reported $170M in 2020. Since its launch in 2013, Doctolib has shown consistent revenue growth.

Doctolib Revenue GrowthReported revenue / ARR over time$0$100M$200M$300M$400M$500M2013201520172019202120232024$0$170M$402.6MSource: GetLatka.com
YearMilestoneSource
2024Doctolib revenue for 2024: $402.6mfrontiers.health
2020Doctolib revenue for 2020: $170mNot recorded
2019Doctolib revenue for 2019: $150mNot recorded
2013Launched with $0 revenue

Doctolib Valuation, Funding Rounds

Doctolib reached a $6.4B valuation in 2022, set during its Series F round.

Doctolib has raised $829.8M in total funding across 7 rounds, most recently a $553.5M Series F round in 2022.

Doctolib Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$1.5B$200M$3B$400M$4.5B$600M$6B$800M$7.5B$1B201320152017201920212022$6.4BSource: GetLatka.com
YearRoundAmountValuation% SoldSource
2022Series F$553.5M$6.4B9%Not recorded
2019Valuation-$1.3B-Not recorded
2019Series E$180.3M--Not recorded
2017Series D$42M--Not recorded
2017Series C$28M--Not recorded
2015Series B$20M--Not recorded
2014Series A$4.8M--Not recorded
2014Seed$1.2M--Not recorded

Doctolib Employees & Team Size

Doctolib employs approximately 2.8K people as of 2026, down from 3.1K in 2024, including 577 sales reps that carry a quota.

Doctolib Team GrowthReported headcount over time07501,5002,2503,0003,7502013201520172019202120232025002,7872,787Source: GetLatka.com
YearMilestoneSource
2025Reached 2.8K employees (November 2025)Not recorded
2024Reached 3.1K employees (March 2024)Latka Top 250 List
2023Reached 3.1K employees (December 2023)Not recorded
2022Reached 2.9K employees (December 2022)Not recorded
2022Reached 2.5K employees (March 2022)Not recorded
2021Reached 2.3K employees (December 2021)Not recorded
2021Reached 1.3K employees (April 2021)Not recorded

Frequently Asked Questions about Doctolib

What is Doctolib's revenue?

As of 2024, Doctolib generated $402.6M in revenue.

What is Doctolib's valuation?

As of 2022, Doctolib was valued at $6.4B.

Who founded Doctolib?

Doctolib was founded by Stanislas Niox-Chateau.

When was Doctolib founded?

Doctolib was founded in 2013.

Who is the CEO of Doctolib?

The CEO of Doctolib is Stanislas Niox-Chateau.

How much funding does Doctolib have?

Doctolib raised $829.8M across 7 rounds.

How many employees does Doctolib have?

As of 2025, Doctolib had 2.8K employees.

Where is Doctolib headquartered?

Doctolib is headquartered in Paris, France.

Compare Doctolib to the industry

Doctolib operates across multiple industries. Browse revenue, funding, and growth data for Doctolib in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile